Synthesis of new quinoline derivatives as inhibitors of human tumor cells growth

53Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A series of new 8-[(2H-tetrazol-5-yl)methoxy]quinoline derivatives, their sugar hydrazones, and their N-glycoside derivatives were synthesized. Furthermore, the 1,2,4-triazole-3-one derivatives 3 and 4 were synthesized from the amidrazone derivative 2. Some of the newly prepared compounds demonstrated inhibitory effects on the growth of MCF-7 human breast cancer cells as compared with the activity of the commonly used anticancer drug, cisplatin. The results of antitumor evaluation revealed that compounds 2-5, 8b, and 12 inhibited the growth of cancer cells through their effect as free-radical regulators by increasing the activity of superoxide dismutase and depletion of intracellular levels of reduced glutathione, catalase and glutathione peroxidase activities, accompanied with a high production of hydrogen peroxide, nitric oxide, and other free radicals causing the killing of tumor cells. The results suggested that the prepared compounds possess significant anticancer activity comparable to cisplatin and the antitumor activity of these prepared compounds was accompanied with a reduction in the levels of protein and nucleic acids. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.

Cite

CITATION STYLE

APA

Rashad, A. E., El-Sayed, W. A., Mohamed, A. M., & Ali, M. M. (2010). Synthesis of new quinoline derivatives as inhibitors of human tumor cells growth. Archiv Der Pharmazie, 343(8), 440–448. https://doi.org/10.1002/ardp.201000002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free